| 0 (0%) | 09-27 14:45 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.06 |
1-year : | 1.34 |
| Resists | First : | 0.9 |
Second : | 1.14 |
| Pivot price | 0.9 |
|||
| Supports | First : | 0.52 |
Second : | 0.43 |
| MAs | MA(5) : | 0.78 |
MA(20) : | 0.92 |
| MA(100) : | 0.57  |
MA(250) : | 0.46 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 25.5 |
D(3) : | 32.3 |
| RSI | RSI(14): 30.9 |
|||
| 52-week | High : | 1.14 | Low : | 0.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ NYMX ] has closed below the lower bollinger band by 14.5%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 77% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.7 - 0.71 | 0.71 - 0.72 |
| Low: | 0.51 - 0.52 | 0.52 - 0.52 |
| Close: | 0.62 - 0.63 | 0.63 - 0.64 |
Tue, 21 Mar 2023
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer - Stock Titan
Tue, 27 Sep 2022
A Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider increased their holdings by 32% last year - Yahoo Finance
Sat, 04 Apr 2015
Is Nymox Pharmaceutical Corp. (NASDAQ:NYMX)Back in Action? - Stocks.org
Thu, 20 Dec 2012
Nymox Pharma Secures Commitment For $15 Mln In Equity Financing - Quick Facts - RTTNews
Tue, 12 Jun 2012
Nymox Starts Phase 2 Enrollment For Low Risk Prostate Cancer Trial - RTTNews
Thu, 22 Jul 2010
NYMEX - CME Group
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.04 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|